Relmada Therapeutics, Inc. - Common Stock (NQ:RLMD)
Price and Volume
Detailed Quote| Volume | 974,997 |
| Open | 4.700 |
| Bid (Size) | 4.050 (900) |
| Ask (Size) | 4.060 (400) |
| Prev. Close | 4.160 |
| Today's Range | 3.815 - 4.710 |
| 52wk Range | 3.070 - 8.000 |
| Shares Outstanding | 17,472,986 |
| Dividend Yield | N/A |
Top News
More News
Performance
52-Week Range
49.3% below 52-week high
4.060
3.0752W Low
8.0052W High
1 Week
10.3% below 1-week high
3.691W Low
4.531W High
Relmada Therapeutics, Inc. - Common Stock (RLMD) traded between $3.07 and $8.00 over the past 52 weeks and last traded at $4.06, 49.3% below its 52-week high. Over the past week it ranged between $3.69 and $4.53.
Past 12 Months
1W
+$0.16
1M
+$0.70
3M
-$0.69
6M
-$3.36
YTD
-$0.31
1Y
+$0.15
RLMD was +3.8% over the past year, -45.3% over six months, -7.1% year to date, +4.1% in the last week.
12 Months vs Market
RLMD
+3.8%
DIA
+8.3%
SPY
+10.3%
QQQ
+9.4%
IWM
+13.8%
Over the past 12 months RLMD returned +3.8% versus DIA (Dow) +8.3%, SPY (S&P 500) +10.3%, QQQ (Nasdaq 100) +9.4% and IWM (Russell 2000) +13.8%.
Volume & Liquidity
0.72× 3-mo avg
Today 974,997
3-mo avg 1.3M
1W
1.1M
1M
1.6M
3M
1.3M
6M
1.6M
YTD
1.5M
1Y
1.4M
RLMD most recently traded 974,997 shares against a 3-month average daily volume of 1.3M.
More News
Read More
Postmarket Movers: After-Hours Gainers and Losers for Nov. 12, 2026 ↗
November 12, 2026
Relmada (RLMD) Q2 2026 Earnings Call Transcript ↗
August 14, 2026
Relmada Therapeutics Q2 Earnings Call Highlights ↗
August 07, 2026
Relmada Therapeutics Q1 Earnings Call Highlights ↗
May 12, 2026
Relmada (RLMD) Q4 2025 Earnings Call Transcript ↗
March 19, 2026
Earnings Scheduled For November 13, 2025 ↗
November 13, 2025
Unusual volume stocks in Tuesday's session ↗
March 10, 2026
Top stock movements in today's session. ↗
March 09, 2026
Monday's session: top gainers and losers ↗
March 09, 2026
Gapping stocks in Monday's session ↗
March 09, 2026
Wondering what's happening in today's pre-market session? ↗
March 09, 2026
Relmada (RLMD) Q3 2025 Earnings Call Transcript ↗
November 13, 2025
A Glimpse of Relmada Therapeutics's Earnings Potential ↗
November 12, 2025
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
November 04, 2025
12 Health Care Stocks Moving In Monday's Intraday Session ↗
October 06, 2025
12 Health Care Stocks Moving In Friday's Intraday Session ↗
October 03, 2025
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
September 04, 2025
On Wednesday, there are stocks with unusual volume. Let's take a look. ↗
September 03, 2025
Frequently Asked Questions
Is Relmada Therapeutics, Inc. - Common Stock publicly traded?
Yes, Relmada Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Relmada Therapeutics, Inc. - Common Stock trade on?
Relmada Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Relmada Therapeutics, Inc. - Common Stock?
The ticker symbol for Relmada Therapeutics, Inc. - Common Stock is RLMD on the Nasdaq Stock Market
What is the current price of Relmada Therapeutics, Inc. - Common Stock?
The current price of Relmada Therapeutics, Inc. - Common Stock is 4.060
When was Relmada Therapeutics, Inc. - Common Stock last traded?
The last trade of Relmada Therapeutics, Inc. - Common Stock was at 11/13/26 02:11 PM ET
What is the market capitalization of Relmada Therapeutics, Inc. - Common Stock?
The market capitalization of Relmada Therapeutics, Inc. - Common Stock is 70.94M
How many shares of Relmada Therapeutics, Inc. - Common Stock are outstanding?
Relmada Therapeutics, Inc. - Common Stock has 71M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.